Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characteristics and predictors of post-transplant-associated hemophagocytic lymphohistiocytosis in adults.
Hattori N, Sato M, Uesugi Y, Nakata A, Sasaki Y, Shimada S, Watanuki M, Fujiwara S, Kawaguchi Y, Arai N, Uto Y, Matsui T, Yanagisawa K, Tahara S, Koeffler HP, Iezumi K, Nakamaki T. Hattori N, et al. Among authors: watanuki m. Int J Hematol. 2021 May;113(5):693-702. doi: 10.1007/s12185-020-03067-6. Epub 2021 Jan 1. Int J Hematol. 2021. PMID: 33385294
Fludarabine Melphalan, Reduced-dose Busulfan Versus Fludarabine, Melphalan, Full-dose Busulfan in Patients Receiving Cord Blood Transplantation.
Arai N, Narita H, Kuroiwa K, Nagao K, Hayashi H, Kawamata N, Okamura R, Sasaki Y, Shimada S, Watanuki M, Kawaguchi Y, Yanagisawa K, Hattori N. Arai N, et al. Among authors: watanuki m. Transplant Proc. 2024 Oct;56(8):1828-1835. doi: 10.1016/j.transproceed.2024.08.031. Epub 2024 Sep 3. Transplant Proc. 2024. PMID: 39232926
Status of Natural Killer Cell Recovery in Day 21 Bone Marrow after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome.
Hattori N, Saito B, Sasaki Y, Shimada S, Murai S, Abe M, Baba Y, Watanuki M, Fujiwara S, Kawaguchi Y, Arai N, Kabasawa N, Tsukamoto H, Uto Y, Ariizumi H, Yanagisawa K, Harada H, Nakamaki T. Hattori N, et al. Among authors: watanuki m. Biol Blood Marrow Transplant. 2018 Sep;24(9):1841-1847. doi: 10.1016/j.bbmt.2018.05.007. Epub 2018 May 16. Biol Blood Marrow Transplant. 2018. PMID: 29753837 Free article.
Monitoring TIGIT/DNAM-1 and PVR/PVRL2 Immune Checkpoint Expression Levels in Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia.
Hattori N, Kawaguchi Y, Sasaki Y, Shimada S, Murai S, Abe M, Baba Y, Watanuki M, Fujiwara S, Arai N, Kabasawa N, Tsukamoto H, Uto Y, Yanagisawa K, Saito B, Harada H, Nakamaki T. Hattori N, et al. Among authors: watanuki m. Biol Blood Marrow Transplant. 2019 May;25(5):861-867. doi: 10.1016/j.bbmt.2019.01.013. Epub 2019 Jan 11. Biol Blood Marrow Transplant. 2019. PMID: 30639819 Free article.
Impact of CD123 expression, analyzed by immunohistochemistry, on clinical outcomes in patients with acute myeloid leukemia.
Arai N, Homma M, Abe M, Baba Y, Murai S, Watanuki M, Kawaguchi Y, Fujiwara S, Kabasawa N, Tsukamoto H, Uto Y, Ariizumi H, Yanagisawa K, Hattori N, Saito B, Shiozawa E, Harada H, Yamochi-Onizuka T, Nakamaki T, Takimoto M. Arai N, et al. Among authors: watanuki m. Int J Hematol. 2019 May;109(5):539-544. doi: 10.1007/s12185-019-02616-y. Epub 2019 Mar 7. Int J Hematol. 2019. PMID: 30847774 Clinical Trial.
Comparative Study of Tacrolimus and Short-Term Methotrexate: 2-Day versus 3-Day Methotrexate as Graft-versus-Host-Disease Prophylaxis after Umbilical Cord Blood Transplantation in Adults.
Hattori N, Saito B, Matsui T, Nakata A, Sasaki Y, Shimada S, Murai S, Abe M, Baba Y, Watanuki M, Fujiwara S, Kawaguchi Y, Arai N, Kabasawa N, Tsukamoto H, Uto Y, Yanagisawa K, Harada H, Nakamaki T. Hattori N, et al. Among authors: watanuki m. Biol Blood Marrow Transplant. 2020 Feb;26(2):367-372. doi: 10.1016/j.bbmt.2019.10.022. Epub 2019 Oct 31. Biol Blood Marrow Transplant. 2020. PMID: 31678538 Free article.
126 results